- Home
- CRNT vs TSHA Comparison
CRNT vs TSHA Comparison
Compare CRNT & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNT
- TSHA
- Stock Information
- Founded
- CRNT 1996
- TSHA 2019
- Country
- CRNT Israel
- TSHA United States
- Employees
- CRNT N/A
- TSHA N/A
- Industry
- CRNT Radio And Television Broadcasting And Communications Equipment
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- CRNT Technology
- TSHA Health Care
- Exchange
- CRNT Nasdaq
- TSHA Nasdaq
- Market Cap
- CRNT 303.2M
- TSHA 356.7M
- IPO Year
- CRNT 2000
- TSHA 2020
- Fundamental
- Price
- CRNT $2.39
- TSHA $1.93
- Analyst Decision
- CRNT Strong Buy
- TSHA Strong Buy
- Analyst Count
- CRNT 5
- TSHA 8
- Target Price
- CRNT $6.15
- TSHA $6.63
- AVG Volume (30 Days)
- CRNT 1.2M
- TSHA 1.7M
- Earning Date
- CRNT 05-06-2025
- TSHA 05-13-2025
- Dividend Yield
- CRNT N/A
- TSHA N/A
- EPS Growth
- CRNT 285.71
- TSHA N/A
- EPS
- CRNT 0.27
- TSHA N/A
- Revenue
- CRNT $394,190,000.00
- TSHA $8,333,000.00
- Revenue This Year
- CRNT $3.36
- TSHA N/A
- Revenue Next Year
- CRNT $7.39
- TSHA N/A
- P/E Ratio
- CRNT $8.85
- TSHA N/A
- Revenue Growth
- CRNT 13.54
- TSHA N/A
- 52 Week Low
- CRNT $2.33
- TSHA $1.19
- 52 Week High
- CRNT $5.73
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- CRNT 31.87
- TSHA 64.48
- Support Level
- CRNT $2.49
- TSHA $1.59
- Resistance Level
- CRNT $2.65
- TSHA $1.87
- Average True Range (ATR)
- CRNT 0.12
- TSHA 0.12
- MACD
- CRNT 0.05
- TSHA 0.02
- Stochastic Oscillator
- CRNT 12.50
- TSHA 94.44
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and global distribution of its business, providing high-capacity wireless connectivity solutions to global markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the major revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.